At a glance
ClinicalIndex Comparison RecordN/ACompleted· 109 enrolled
Drug / intervention
Exufiber Ag+ +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Clinical Investigation to Study the Effect of Exufiber Ag+ and Other Gelling Fibre Dressings on Wound Exudate and Bioburden in Medium to High Exuding Wounds
In Brief
A clinical study evaluating Exufiber Ag+, Exufiber, and 1 other intervention for Wounds and Injuries. Completed, enrolled 109 participants across 8 sites.
Detailed Summary
Investigate impact of gelling fiber dressings on handling exudate in medium to high exuding wounds
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWounds and Injuries
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartAug 2017
First PostedAug 2017
Primary CompletionAug 2019
TodayJul 2026
First PostedAug 15, 2017
Enrollment StartAug 11, 2017
Primary CompletionAug 19, 2019
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 8.9 years ago
Interventions
Exufiber Ag+device
gelling fibre dressing with silver
Exufiberdevice
gelling fibre without silver
Aquacel Ag Extradevice
gelling fibre with silver